Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets
Ellen Heitzer(Medical University of Graz), Bernadette Liegl‐Atzwanger(Medical University of Graz), Magdalena M. Gilg(Medical University of Graz), Peter Ulz(Freenome (United States)), Sandra Sunitsch(Medical University of Graz), Karl Kashofer(Medical University of Graz), Joanna Szkandera(Medical University of Graz), Birgit Lohberger(Medical University of Graz), Nicole Stündl(Medical University of Graz), Andreas Leithner(Medical University of Graz), Beate Rinner(Medical University of Graz)
Cited by 41
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication
|Brain Behavior and Immunity|2016|741
Germline mutations in BAP1 predispose to melanocytic tumors
|Nature Genetics|2011|724